![]() ![]() | Jorssen, J.* , Van Hulst, G.* , Mollers, K., Pujol, J., Petrellis, G., Baptista, A. P., Schetters, S., Baron, F., Caers, J., Lambrecht, B. N., Dewals, B. G., Bureau, F.* , & Desmet, C.*. (2024). Single-cell proteomics and transcriptomics capture eosinophil development and identify the role of IL-5 in their lineage transit amplification. Immunity. doi:10.1016/j.immuni.2024.04.027 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Van Hulst, G., Jorssen, J., Jacobs, N., Henket, M., Louis, R., Schleich, F., Bureau, F., & Desmet, C. (2022). Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma. European Respiratory Journal. doi:10.1183/13993003.00935-2021 ![]() |
![]() ![]() | Rosu, A., El Hachem, N., Rapino, F., Rouault-Pierre, K., Jorssen, J., SOMJA, J., Ramery, E., Thiry, M., Nguyen, L., Jacquemyn, M., Daelemans, D., Adams, C. M., Bonnet, D., Chariot, A., Close, P., Bureau, F., & Desmet, C. (2021). Loss of tRNA-modifying enzyme Elp3 activates a p53-dependent antitumor checkpoint in hematopoiesis. Journal of Experimental Medicine, 218 (3). doi:10.1084/jem.20200662 ![]() |
![]() ![]() | Van Hulst, G., Batugedara, H. M., Jorssen, J., Louis, R., Bureau, F., & Desmet, C. (2020). Eosinophil diversity in asthma. Biochemical Pharmacology, 179. doi:10.1016/j.bcp.2020.113963 ![]() |